No. |
Name |
Institution |
Project Name |
Patient No. |
Approval date |
20001 |
Tsai, Jih-Jin |
Tropical Medicine Center, Kaohsiung Medical University Chung-Ho Memorial Hospital |
Research and development of COVID-19 precision diagnostics |
30 |
20200422 |
20002 |
Guan-Da Syu |
Department of Biotechnology and Bioindustry Sciences, National Cheng Kung University |
Antibody Profiling of COVID-19 Using Coronavirus Protein and Peptide Microarray |
110 |
20201028 |
20003 |
Liang-Tzung Lin |
Microbiology and Immunology, Taipei Medical University |
Establishment of SARS-CoV-2 Pseudoparticle System as Diagnostic and Therapeutic Testing Platform |
10 |
20200714 |
20004 |
Tan Tse-Hua |
Immunology Research Center, National Healthy Research Institutes |
Signaling Pathways as Therapeutic Targets for COVID-19 infection |
60 |
20201028 |
20005 |
Chang-Wei Li |
AllBio Science, Inc |
The COVID-19 rapid test development |
35 |
20200610 |
20007 |
Yen-Hsu Chen |
Medical School, Kaohsiung Medical University |
Development of a rapid diagnosis CMOS of 2019-nCoV |
55 |
20200714 |
20008 |
Hsiang-Tsui Wang |
Department of Pharmacology, National Yang-Ming University |
Using nano-imaging approaches to reveal the interplay of SARS-CoV-2 spike protein with cellular receptors and SARS-CoV-2 spike protein-induced cellular responses |
90 |
20201230 |
20009 |
Hung-Wei Yang |
Institute of Medical Science and Technology, National Sun Yat-sen University |
A ultrasensitive EasyVial for rapid diagnostic test of viral infections |
90 |
20200714 |
20010 |
Chang-Wei Li |
AllBio Science, Inc |
The COVID-19 rapid test development |
80 |
20200714 |
20011 |
Lung-Wen Tai |
R&D Division, Agnitio Science & Technology, Inc. |
BioIC SARS-CoV2 IgG/IgM Detection Kit-Performance Evaluation |
100 |
20200921 |
20012 |
Ming-Yu Lin |
Department of Biosensing Development, Helios Bioelectronics Inc. |
Detection of protein from COVID-19 serum samples by semiconductor-based biosensors |
10 |
20200812 |
20013 |
Jia-Chuan Hsu |
Section of Biologics, Division of Research and Analysis, Taiwan Food and Drug Administration, Ministry of Health and Welfare |
Preparation of SARS-CoV-2 antibodies for COVID-19 vaccine candidates evaluation |
40 |
20200812 |
20014 |
Evelyn Chen |
BioMedical Sensing Business Division, DELBIO, INC. |
COVID-19 IgG/IgM Rapid Test Clinical Trials |
180 |
20200921 |
20015 |
Pei-Min Chen |
Pre-clinical and clinical study Dept. United Biomedical, Inc., Asia |
Analysis of immunogenicity in COVID-19 convalescent serum samples |
30 |
20200921 |
20016 |
Shu-chen Kuo |
National Institutes of infectious Diseases and Vaccinology, National Healthy Research Institutes |
Antibody responses to SARS-CoV-2 in patients with COVID-19 |
20 |
20200921 |
20017 |
Jia-Chuan Hsu |
Section of Biologics, Division of Research and Analysis, Taiwan Food and Drug Administration, Ministry of Health and Welfare |
Preparation of SARS-CoV-2 antibodies for COVID-19 vaccine candidates evaluation |
55 |
20201028 |
20018 |
Shih-Jen Liu |
National Institute of Infectious Diseases and Vaccinology, National Health Research Institutes |
Development of quantitative rapid test for Covid-19 disease |
70 |
20201119 |
20019 |
Der-Yuan Chen |
Division of Rheumatology and Immunology, China Medical University Hospital |
The associations of hyperferritinemia with disease pathogenesis and COVID-19 infection in rheumatic patients |
30 |
20201119 |
20020 |
Ching-Wei Tsai |
Department of Biosensing Development, Helios Bioelectronics Inc. |
Detection of protein from COVID-19 serum samples by semiconductor-based biosensors |
105 |
20201119 |
20021 |
Yahui Huang |
Division of Human Pharmaceuticals and Diagnostics, Schweitzer Biotech Company Ltd. |
Cross Reactivity Study of SBC COVID-19 IgG ELISA Kit |
80 |
20201230 |
21022 |
Jia-Chuan Hsu |
Section of Biologics, Division of Research and Analysis, Taiwan Food and Drug Administration, Ministry of Health and Welfare |
Preparation of SARS-CoV-2 antibodies for COVID-19 vaccine candidates evaluation |
67 |
20210222 |
21023 |
Tzou Yien Lin |
Department of Pediatrics, Chang Gung Memorial Hospital |
A haemagglutination test for rapid detection of antibodies to SARS-CoV-2 |
100 |
20210421 |
21024 |
Guann-Yi Yu |
National Institute of Infectious Diseases and Vaccinology, National Health Research Institutes |
RNA viral infection and pathogenesis |
35 |
20210421 |
21025 |
Guan-Da Syu |
Department of Biotechnology and Bioindustry Sciences, National Cheng Kung University |
Antibody Profiling of COVID-19 Using Coronavirus Protein and Peptide Microarray |
60 |
20210625 |
21026 |
Hsiang-Ju Chen |
Molecular Virology, LumiSTAR Biotechnology, Inc. |
Development of rapid SARS-CoV-2 Neutralizing Antibody Serologic Detection Kit |
160 |
20210625 |
21027 |
Kent Yeh |
Product development department, Avirovac |
SARS-CoV-2 Neutralization Antibody ELISA Development |
60 |
20210625 |
21028 |
Der-Yuan Chen |
Division of Rheumatology and Immunology, China Medical University Hospital |
The association of anti-cytokine antibodies with disease activity parameters and infection in rheumatic patients |
120 |
20210820 |
21029 |
Hsin-Chou Yang |
Institute of Statistical Science, Academia Sinica |
Establishing NGS analytical model for understanding the infectious program of SARS-CoV-2 |
200 |
20211007 |
21030 |
Yahui Huang |
Division of Human Pharmaceuticals and Diagnostics |
Clinical Agreement Study of SBC COVID-19 ELISA |
80 |
20211007 |
21031 |
Tsai, Jih-Jin |
Tropical Medicine Center, Kaohsiung Medical University Chung-Ho Memorial Hospital |
Research and development of COVID-19 precision diagnostics |
120 |
20211217 |
21032 |
Tsai-Ling Liao |
Department of Medical Research, Taichung Veterans General Hospital |
The pathogenic role of extracellular vesicles and cellular factors in COVID-19 |
20 |
20220223 |
22033 |
Chun Liang Shih |
Panion & BF Biotech inc. |
Evaluation of the detection performance of Vstrip COVID-19 S-RBD Antibody Rapid Test for sera of patients infected with COVID-19 variant strains |
18 |
20220421 |
22034 |
Chao-Lun Lai |
Department of Internal Medicine, National Taiwan University Hospital Hsin-Chu Branch |
Comparison of neutralizing antibody levels against SARS-CoV-2 variants before and after the third SARS-CoV-2 booster shot |
55 |
20220617 |
22035 | Shih-Hsien Hsu | Graduate Institute of Medicine, Kaohsiung Medical University | ISX-induced hepatic steatosis impacts the progression of COVID-19 | 100 | 20220831 |
22036 | Hsiang-Tsui Wang | Department of Pharmacology, National Yang Ming Chiao Tung University | Using nano-imaging approaches to reveal the interplay of SARS-CoV-2 spike protein with cellular receptors and SARS-CoV-2 spike proteininduced cellular responses. | 250 | 20221024 |
22037 | Yu-Li Liu | Center for Neuropsychiatric Research, National Health Research Institutes | Preliminary study on the correlation between brain nerve damage and biomarkers for disease symptoms in patients with COVID | 200 | 20230104 |
23038 | Hu Ching-Wen | Nursing department, Tung’s Taichung MetroHarbor Hospital | Clinical characteristics of mild COVID-19 with DM patients in Taiwan | 250 | 20230222 |
23039 | Shih-Cheng Chen | National Institute Cancer Research, National Health Research Institutes | Validation of genetic variations associated to severe Covid-19 from NBCT data | 250 | 20230419 |
23040 | Yu-Li Liu | Center for Neuropsychiatric Research, National Health Research Institutes | Preliminary study on the correlation between brain nerve damage and biomarkers for disease symptoms in patients with COVID | 200 | 20230420 |
23041 | Yu-Li Liu | Center for Neuropsychiatric Research, National Health Research Institutes | Preliminary study on the correlation between brain nerve damage and biomarkers for disease symptoms in patients with COVID | 200 | 20231213 |
23042 | Yu-Li Liu | Center for Neuropsychiatric Research, National Health Research Institutes | Preliminary study on the correlation between brain nerve damage and biomarkers for disease symptoms in patients with COVID | 250 | 20231213 |
24043 | Guan-Da Syu | Department of Biotechnology and Bioindustry Sciences, National Cheng Kung University | Antibody Profiling of COVID-19 Using Coronavirus Protein and Peptide Microarray | 60 | 20240227 |